San Diego, June 2, 2020 – Origami Therapeutics, an early stage biotech company taking a precision medicine approach to find disease-modifying treatments for neurodegenerative diseases caused by protein folding, announced today it has been selected as one of the 60...

San Diego, May 21, 2020 – Origami Therapeutics has been selected as a finalist in the forthcoming Digital RESI June Conference Innovation Challenge. Companies were selected on the basis of innovative technology, strong management team, clear pathway to...

San Diego, May 13, 2020 – Beth Hoffman, CEO and President of Origami Therapeutics Inc has been announced as a panelist and speaker at the upcoming Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare, currently scheduled to take place in...